Forskning
Udskriv Udskriv
Switch language
Bispebjerg Hospital - en del af Københavns Universitetshospital
Udgivet

CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Polyunsaturated fatty acids and prostate cancer risk: a Mendelian randomisation analysis from the PRACTICAL consortium

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Long working hours and cancer risk: a multi-cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Chronic lymphocytic leukaemia clones are detectable decades before diagnosis

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  2. Rare germline copy number variants (CNVs) and breast cancer risk

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Long-term benefits and harms associated with genetic cholesteryl ester transfer protein deficiency in the general population

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Occupational inhalant exposures and longitudinal lung function decline

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • NBCS Collaborators
Vis graf over relationer

BACKGROUND: Epidemiological studies provide strong evidence for a role of endogenous sex hormones in the aetiology of breast cancer. The aim of this analysis was to identify genetic variants that are associated with urinary sex-hormone levels and breast cancer risk.

METHODS: We carried out a genome-wide association study of urinary oestrone-3-glucuronide and pregnanediol-3-glucuronide levels in 560 premenopausal women, with additional analysis of progesterone levels in 298 premenopausal women. To test for the association with breast cancer risk, we carried out follow-up genotyping in 90,916 cases and 89,893 controls from the Breast Cancer Association Consortium. All women were of European ancestry.

RESULTS: For pregnanediol-3-glucuronide, there were no genome-wide significant associations; for oestrone-3-glucuronide, we identified a single peak mapping to the CYP3A locus, annotated by rs45446698. The minor rs45446698-C allele was associated with lower oestrone-3-glucuronide (-49.2%, 95% CI -56.1% to -41.1%, P = 3.1 × 10-18); in follow-up analyses, rs45446698-C was also associated with lower progesterone (-26.7%, 95% CI -39.4% to -11.6%, P = 0.001) and reduced risk of oestrogen and progesterone receptor-positive breast cancer (OR = 0.86, 95% CI 0.82-0.91, P = 6.9 × 10-8).

CONCLUSIONS: The CYP3A7*1C allele is associated with reduced risk of hormone receptor-positive breast cancer possibly mediated via an effect on the metabolism of endogenous sex hormones in premenopausal women.

OriginalsprogEngelsk
TidsskriftBritish Journal of Cancer
Vol/bind124
Udgave nummer4
Sider (fra-til)842-854
Antal sider13
ISSN0007-0920
DOI
StatusUdgivet - 16 feb. 2021

Bibliografisk note

Funding Information:
Competing interests M.W.B. conducts research funded by Amgen, Novartis and Pfizer. P.A.F. conducts research funded by Amgen, Novartis and Pfizer. He received honoraria from Roche, Novartis and Pfizer. A.W.K.’s institution has received research funding from Myriad Genetics for an unrelated project (funding dates 2017–2019). P.H., .P.D.P.P., O.F., K.C. and A.C. are members of the Editorial Board of BJC. The remaining authors declare no competing interests.

ID: 61899580